Literature DB >> 1503349

Patent foramen ovale as a risk factor for cryptogenic stroke.

M Di Tullio1, R L Sacco, A Gopal, J P Mohr, S Homma.   

Abstract

OBJECTIVE: To determine and compare the prevalence of patent foramen ovale in patients with stroke of undetermined origin (cryptogenic) and in patients with stroke of determined origin to assess the possible role of patent foramen ovale as a risk factor for cryptogenic stroke.
DESIGN: Cross-sectional study with nested case-control analysis. PATIENTS: A total of 146 patients (73 men, 73 women) with acute ischemic stroke referred to the echocardiography laboratory for evaluation.
SETTING: Neurovascular Unit and Echocardiography Laboratory, Columbia-Presbyterian Medical Center, New York, New York. MEASUREMENTS: Patients were considered to have strokes of determined origin or cryptogenic strokes according to National Institute of Neurological Disorders and Stroke (NINDS) Stroke Data Bank criteria. The presence of patent foramen ovale was assessed by contrast echocardiography, performed blinded for type of stroke. The association between patent foramen ovale and type of stroke was tested after correcting for patients' demographic variables and stroke risk factors.
RESULTS: The overall prevalence of patent foramen ovale was 26 of 146 patients (18%; 95% Cl, 11.4% to 24.6%). Patients with cryptogenic stroke (31%) had a significantly higher prevalence of patent foramen ovale than did patients with an identifiable cause of stroke (69%) in both the younger (less than 55 years; 48% compared with 4%; P less than 0.001) and the older (greater than or equal to 55 years; 38% compared with 8%; P less than 0.001) age groups. Multiple logistic regression analysis was used to identify the presence of a patent foramen ovale as strongly associated with the diagnosis of cryptogenic stroke (odds ratio, 7.2; Cl, 2.4 to 21.7), irrespective of patient age and other stroke risk factors.
CONCLUSIONS: Patients with cryptogenic stroke have a higher prevalence of patent foramen ovale than patients with stroke of determined cause in all age groups, even after correcting for the presence of recognized stroke risk factors. This identifies patent foramen ovale as a risk factor for cryptogenic stroke. Regardless of patient age, contrast echocardiography should be considered when the cause of stroke is unknown.

Entities:  

Mesh:

Year:  1992        PMID: 1503349     DOI: 10.7326/0003-4819-117-6-461

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  96 in total

1.  Transcranial Doppler ultrasonography in the detection of venous to arterial shunting in acute stroke and transient ischaemic attacks.

Authors:  M Yeung; K A Khan; A Shuaib
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

2.  The management of patients with patent foramen ovale and stroke.

Authors:  Irene Meissner
Journal:  Curr Treat Options Neurol       Date:  2005-11       Impact factor: 3.598

3.  How should we assess patent foramen ovale?

Authors:  C Seiler
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

4.  Which treatment for patent foramen ovale in cryptogenic stroke?

Authors:  Isabelle Mahé; Charles Caulin; Jean-François Bergmann
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

5.  Right atrial spontaneous contrast: echocardiographic and clinical features.

Authors:  M A DeGeorgia; M I Chimowitz; A Hepner; W F Armstrong
Journal:  Int J Card Imaging       Date:  1994-09

Review 6.  Management of patients with stroke and a patent foramen ovale.

Authors:  Carlos J Rodriguez; Shunichi Homma
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

7.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

8.  Complications and mid-term outcome after percutaneous patent foramen ovale closure in patients with cryptogenic stroke.

Authors:  J G L M Luermans; M C Post; H W M Plokker; J M Ten Berg; M J Suttorp
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

9.  Exercise-induced arteriovenous intrapulmonary shunting in dogs.

Authors:  Michael K Stickland; Andrew T Lovering; Marlowe W Eldridge
Journal:  Am J Respir Crit Care Med       Date:  2007-05-03       Impact factor: 21.405

10.  Cerebral microembolism during transcatheter closure of patent foramen ovale.

Authors:  J Ferrari; H Baumgartner; S Tentschert; V Dorda; W Lang; A Willfort-Ehringer; P Probst; W Lalouschek
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.